The treatment of a specific subtype of highly malignant brain tumor (called "glioblastoma" or "glioblastoma multiforme") consists of neurosurgical resection, followed by radiotherapy and mostly chemotherapy as well. Increased extent of tumor resection is associated with prolonged survival. The standard treatment uses conventional neuronavigation systems to increase extent of tumor resection. However, the quality of this form of neuronavigation decreases throughout surgery because of "brain shift". This is caused by edema, loss of cerebrospinal fluid and tumor resection. A new form of neuronavigation uses intraoperative MRI to compensate for brain shift, and to check for the presence of residual tumor that can be removed. This study aims to compare the extent of glioblastoma resection between the standard treatment and intraoperative MRI.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
14
Neuronavigation based on preoperative MRI
Intraoperative MRI guided surgery
Centre Hospitalier Universitaire de Liege
Liège, Belgium
Maastricht University Medical Center
Maastricht, Netherlands
Difference in Residual tumor volume
Time frame: <72h after surgery
Complications, Clinical Performance, and Quality of Life
Time frame: 3 months after surgery
Survival
Time frame: 2 years after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.